Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL02503NANCT00081497Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL03204NANCT00140621Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL06207FIELDNCT00701415Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL19110NAEudraCT: 2012-001966-14Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
AGAL19412NANCT01650779Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry Disease
DIREGC07006NANCT00196742 Publication Reference
AGALSIDASE BETA
Fabrazyme
Fabry Disease
FB9702-01*NASummary
AGALSIDASE BETA
Fabrazyme
Fabry Disease
LPS16583NAEudraCT Number: 2023-000624-11Tabulated Results
AGALSIDASE BETA
Fabrazyme
Fabry disease
MSC12868/AGAL02603NANCT00230607Tabulated Results
ALEMTUZUMAB
Lemtrada
Multiple Sclerosis
ALEMLL08091LemCourseEudraCT: 2016-000464-42Tabulated Results

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted